Page last updated: 2024-12-10

cucurbitacin i

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cucurbitacin I: toxic constituent in edible gourd; see also records for cucurbitacins & specific cucurbitacins [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cucurbitacin I : A cucurbitacin that is 9,10,14-trimethyl-4,9-cyclo-9,10-secocholesta-2,5,23-triene substituted by hydroxy groups at positions 2, 16, 20 and 25 and oxo groups at positions 1, 11 and 22. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5281321
CHEMBL ID387737
CHEBI ID3947
SCHEMBL ID2523066
SCHEMBL ID15914446
MeSH IDM0114859

Synonyms (50)

Synonym
unii-shq47990ph
shq47990ph ,
LMST01010110
2,16alpha,20,25-tetrahydroxy-9beta-methyl-10alpha-19-norlanosta-1,5,23(e)-triene-3,11,22-trione
nsc 521777
19-norlanosta-1,5,23-triene-3,11,22-trione, 2,16,20,25-tetrahydroxy-9-methyl-, (9beta,10alpha,16alpha)-
nsc 112167
19-norlanosta-1,5,23-triene-3,11,22-trione, 2,16,20,25-tetrahydroxy-9-methyl-, (9beta,10alpha,16alpha)- (van)
einecs 218-736-8
19-nor-9-beta,10-alpha-lanosta-1,5,23-triene-3,11,22-trione, 9-methyl-2,16,20,25-tetrahydroxy-
NSC521777 ,
(8s,9r,10r,13r,14s,16r,17r)-17-[(e,1r)-1,5-dihydroxy-1,5-dimethyl-2-oxo-hex-3-enyl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-8,10,12,15,16,17-hexahydro-7h-cyclopenta[a]phenanthrene-3,11-dione
19-norlanosta-1,5,23-triene-3,11,22-trione, 2,16,20,25-tetrahydroxy-9-methyl-, (9.beta.,10.alpha.,16.alpha.,23e)-
2222-07-3
elatericin b
nsc-112167
nsc112167
1,2-dehydroelatericin a
19-nor-9.beta.,5,23-triene-3,11,22-trione, 9-methyl-2,16,20,25-tetrahydroxy-
19-norlanosta-1,23-triene-3,11,22-trione, 2,16,20,25-tetrahydroxy-9-methyl-, (9.beta.,10.alpha.,16.alpha.)- (va
cucurbitacine (i)
cucurbitaccine (i)
mls002702902 ,
nsc-521777
C08800
cucurbitacin i
jsi-124
chebi:3947 ,
CHEMBL387737
(8s,9r,10r,13r,14s,16r,17r)-17-[(e,2r)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-8,10,12,15,16,17-hexahydro-7h-cyclopenta[a]phenanthrene-3,11-dione
dtxsid501015546 ,
jsi 124
(4r,9beta,16alpha,23e)-2,16,20,25-tetrahydroxy-9,10,14-trimethyl-4,9-cyclo-9,10-secocholesta-2,5,23-triene-1,11,22-trione
(9?,10?,16?,23e)-2,16,20,25-tetrahydroxy-9-methyl-19-norlanosta-1,5,23-triene-3,11,22-trione
SCHEMBL2523066
SCHEMBL15914446
AKOS024456675
HY-N1405
CS-5431
cucurbitacin i (elatericin b)
Q27106265
elatericin b;jsi-124;nsc-521777
NCGC00388208-02
F85354
MS-29560
nsc-521777elatericin b
2,16,20,25-terahydroxycucurbita-1,5,23-triene-3,11,22-trione - iberis umbellata (candytuft)
XT170627
28580-39-4
elatericin b; jsi-124; nsc-521777

Research Excerpts

Overview

Cucurbitacin I (CBI) is a triterpene from a bitter melon called Goya grown in Okinawa, Japan. CBI inhibits both the Tyr-kinase JAK2 and the G protein RAC, leading to the inactivation of PAK1.

ExcerptReferenceRelevance
"Cucurbitacin I is a naturally occurring triterpenoid derived from Cucurbitaceae family plants that exhibits a number of potentially useful pharmacological and biological activities. "( Cucurbitacin I Attenuates Cardiomyocyte Hypertrophy via Inhibition of Connective Tissue Growth Factor (CCN2) and TGF- β/Smads Signalings.
Jeong, MH; Kang, H; Kim, SJ; Park, KW; Park, WJ; Yang, DK; Yang, SY, 2015
)
3.3
"Cucurbitacin I (CBI) is a triterpene from a bitter melon called Goya grown in Okinawa, Japan, and directly inhibits both the Tyr-kinase JAK2 and the G protein RAC, leading to the inactivation of PAK1 (RAC/CDC42-activated kinase 1). "( Combination of immunoprecipitation (IP)-ATP_Glo kinase assay and melanogenesis for the assessment of potent and safe PAK1-blockers in cell culture.
Be Tu, PT; Maruta, H; Nguyen, BC; Tawata, S, 2015
)
1.86

Treatment

Cucurbitacin I treatment at 100 nM effectively abrogated STAT3 activation, tumorigenic capacity, sphere formation ability, radioresistance, and chemoresistance in CD133-positive NSCLC cells. Cucurbitsa I alone increased pErk1/2 expression in wild-type and Pim-1-overexpressing cell lines.

ExcerptReferenceRelevance
"Cucurbitacin I treatment inhibits the ERK activation and the downstream phosphorylation level of mTOR and STAT3, but not the PI3K/Akt pathway."( Cucurbitacin I induces pro-death autophagy in A549 cells via the ERK-mTOR-STAT3 signaling pathway.
Chen, X; Ding, Y; Jiang, W; Ni, Y; Wang, X; Wu, S; Zhu, G, 2018
)
2.64
"Cucurbitacin I treatment at 100 nM effectively abrogated STAT3 activation, tumorigenic capacity, sphere formation ability, radioresistance, and chemoresistance in CD133-positive NSCLC cells."( Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells.
Chang, YL; Chen, YC; Chen, YW; Chiou, SH; Hsu, HS; Huang, PI; Hung, SC; Shih, HC; Tseng, LM; Tzao, C, 2011
)
2.53
"Cucurbitacin I treatment alone increased pErk1/2 expression in wild-type and Pim-1-overexpressing cell lines and resulted in exaggerated Pim-1 kinase protein levels in control and IL-6-stimulated cells, suggesting that up-regulation of Pim-1 may be partially STAT3 independent."( IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines.
Baker, AF; Block, KM; Hanke, NT; Maine, EA, 2012
)
1.1
"Treatment with cucurbitacin I significantly suppressed the CSC-like properties and stemness gene signature of MB-derived CD133(+) cells."( Inhibition of phosphorylated STAT3 by cucurbitacin I enhances chemoradiosensitivity in medulloblastoma-derived cancer stem cells.
Chang, CH; Chang, CJ; Chiang, CH; Hsu, CC; Huang, CS; Jeng, SY; Lee, HF; Liu, JH; Lu, KH; Song, WS; Tsai, CY; Tsai, SK; Woung, LC; Yung, MC, 2012
)
0.99

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
cucurbitacinAny one of a class of tetracyclic triterpenoids, formally derived from the triterpene hydrocarbon cucurbitane, developed by some plants (especially those of the family Cucurbitaceaeas) as a defence mechanism against herbivores.
tertiary alpha-hydroxy ketoneAn alpha-hydroxy ketone in which the carbonyl group and the hydroxy group are linked by a carbon bearing two organyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Integrin alpha-LHomo sapiens (human)IC50 (µMol)0.95000.00080.60203.7800AID337982
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cellIntegrin alpha-LHomo sapiens (human)
phagocytosisIntegrin alpha-LHomo sapiens (human)
inflammatory responseIntegrin alpha-LHomo sapiens (human)
cell adhesionIntegrin alpha-LHomo sapiens (human)
heterophilic cell-cell adhesion via plasma membrane cell adhesion moleculesIntegrin alpha-LHomo sapiens (human)
leukocyte cell-cell adhesionIntegrin alpha-LHomo sapiens (human)
cell-matrix adhesionIntegrin alpha-LHomo sapiens (human)
signal transductionIntegrin alpha-LHomo sapiens (human)
integrin-mediated signaling pathwayIntegrin alpha-LHomo sapiens (human)
memory T cell extravasationIntegrin alpha-LHomo sapiens (human)
receptor clusteringIntegrin alpha-LHomo sapiens (human)
cell-cell adhesionIntegrin alpha-LHomo sapiens (human)
cell adhesion mediated by integrinIntegrin alpha-LHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
protein bindingIntegrin alpha-LHomo sapiens (human)
ICAM-3 receptor activityIntegrin alpha-LHomo sapiens (human)
metal ion bindingIntegrin alpha-LHomo sapiens (human)
cell adhesion molecule bindingIntegrin alpha-LHomo sapiens (human)
integrin bindingIntegrin alpha-LHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (8)

Processvia Protein(s)Taxonomy
plasma membraneIntegrin alpha-LHomo sapiens (human)
cell surfaceIntegrin alpha-LHomo sapiens (human)
membraneIntegrin alpha-LHomo sapiens (human)
integrin alphaL-beta2 complexIntegrin alpha-LHomo sapiens (human)
specific granule membraneIntegrin alpha-LHomo sapiens (human)
extracellular exosomeIntegrin alpha-LHomo sapiens (human)
integrin complexIntegrin alpha-LHomo sapiens (human)
external side of plasma membraneIntegrin alpha-LHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (45)

Assay IDTitleYearJournalArticle
AID479451Inhibition of LIMK1/2 phosphorylation in human U937 cells at 0.1 to 1000 nM after 24 hrs by Western blotting2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells.
AID592715Hepatoprotective activity in human HepG2 cells assessed as inhibition of CCl4-induced toxicity after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines.
AID592721Cytotoxicity against rat HSC-T6 cell after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines.
AID1225605Cytotoxicity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTS/PMS assay2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID1683897Induction of LDR uptake in human HepG2 cells at 5 uM by DIL probe based fluorescence assay2020Journal of natural products, 12-24, Volume: 83, Issue:12
Lipid-Lowering Activities of Cucurbitacins Isolated from
AID479447Inhibition of cofilin phosphorylation in human U937 cells after 24 hrs by Western blotting2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells.
AID592722Antiproliferative activity against serum-stimulated rat HSC-T6 cells after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines.
AID479450Decrease of F to G actin ratio in human HT1080 cells at 1000 nM after 24 hrs2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells.
AID354488Growth inhibition of human colon cancer cells2004Journal of natural products, Aug, Volume: 67, Issue:8
An analysis of cytotoxic botanical formulations used in the traditional medicine of ancient Persia as abortifacients.
AID1225626Inhibition of HSP90 in human MCF7 cells assessed as induction of heat shock response-mediated HSP70 production at 0.5 times to 5 times IC50 after 24 hrs by Western blot analysis2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID337991Inhibition of actin polymerization in fMLP-stimulated human neutrophils assessed as positive fluorescence signal at 1 uM1994Journal of natural products, Nov, Volume: 57, Issue:11
Cucurbitacins, cell adhesion inhibitors from Conobea scoparioides.
AID592714Cytotoxicity against human HepG2 cells after 24 hrs assessed as inhibition of cell viability by MTT assay2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines.
AID1225627Inhibition of HSP90 in human MCF7 cells assessed as induction of heat shock response-mediated HSP27 production at 0.5 times to 5 times IC50 after 24 hrs by Western blot analysis2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID354490Growth inhibition of human lung cancer cells2004Journal of natural products, Aug, Volume: 67, Issue:8
An analysis of cytotoxic botanical formulations used in the traditional medicine of ancient Persia as abortifacients.
AID1225625Inhibition of HSP90 in human MCF7 cells assessed as induction of heat shock response-mediated HSP90 production at 0.5 times to 5 times IC50 after 24 hrs by Western blot analysis2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID282344Inhibition of human AICAR Tfase2004Journal of medicinal chemistry, Dec-30, Volume: 47, Issue:27
Virtual screening of human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase against the NCI diversity set by use of AutoDock to identify novel nonfolate inhibitors.
AID1424460Growth inhibition of human A549 cells2017European journal of medicinal chemistry, Dec-15, Volume: 142From bench (laboratory) to bed (hospital/home): How to explore effective natural and synthetic PAK1-blockers/longevity-promoters for cancer therapy.
AID1225624Inhibition of HSP90 in human MCF7 cells assessed as Raf degradation at 0.5 times to 5 times IC50 after 24 hrs by Western blot analysis2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID592718Ratio of IC50 to EC50 for hepatoprotective activity in human HepG2 cells2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines.
AID592724Hepatoprotective activity in human HepG2 cells assessed as protection against cell damage after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines.
AID337984Cytotoxicity against human JY cells assessed as inhibition of thymidine uptake at 1 uM by scintillation counting1994Journal of natural products, Nov, Volume: 57, Issue:11
Cucurbitacins, cell adhesion inhibitors from Conobea scoparioides.
AID319043Cytotoxicity against human C8166 cells by MTT method2008Journal of natural products, Jan, Volume: 71, Issue:1
Octanorcucurbitane and cucurbitane triterpenoids from the tubers of Hemsleya endecaphylla with HIV-1 inhibitory activity.
AID337985Cytotoxicity against human JY cells assessed as inhibition of thymidine uptake at 3.3 uM by scintillation counting1994Journal of natural products, Nov, Volume: 57, Issue:11
Cucurbitacins, cell adhesion inhibitors from Conobea scoparioides.
AID354491Growth inhibition of human CNS cancer cells2004Journal of natural products, Aug, Volume: 67, Issue:8
An analysis of cytotoxic botanical formulations used in the traditional medicine of ancient Persia as abortifacients.
AID354489Growth inhibition of human breast cancer cells2004Journal of natural products, Aug, Volume: 67, Issue:8
An analysis of cytotoxic botanical formulations used in the traditional medicine of ancient Persia as abortifacients.
AID479448Inhibition of LIMK1/2 phosphorylation in human U937 cells at 0.1 to 100 nM after 24 hrs by Western blotting2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells.
AID1225623Inhibition of HSP90 in human MCF7 cells assessed as Cdk6 degradation at 0.5 times to 5 times IC50 after 24 hrs by Western blot analysis2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID319042Antiviral activity against HIV1 in C8166 cells after 72 hrs2008Journal of natural products, Jan, Volume: 71, Issue:1
Octanorcucurbitane and cucurbitane triterpenoids from the tubers of Hemsleya endecaphylla with HIV-1 inhibitory activity.
AID479272Cytotoxicity against human U937 cells after 72 hrs by WST-8 assay2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells.
AID479441Cytotoxicity against human HT1080 cells after 72 hrs by WST-8 assay2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells.
AID337982Inhibition of LFA1 expressed in human JY cells interaction with ICAM1-IG expressed in human HeLa cell monolayer after 45 mins by cell adhesion assay1994Journal of natural products, Nov, Volume: 57, Issue:11
Cucurbitacins, cell adhesion inhibitors from Conobea scoparioides.
AID592719Cytotoxicity against human HeLa cells after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines.
AID479440Cytotoxicity against human HL60 cells after 72 hrs by WST-8 assay2010Bioorganic & medicinal chemistry letters, May-01, Volume: 20, Issue:9
Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells.
AID319044Selectivity index, ratio of CC50 for human C8166 cells to EC50 for HIV12008Journal of natural products, Jan, Volume: 71, Issue:1
Octanorcucurbitane and cucurbitane triterpenoids from the tubers of Hemsleya endecaphylla with HIV-1 inhibitory activity.
AID592723Ratio of IC50 to EC50 for antiproliferative activity in rat HSC-T6 cells2011Bioorganic & medicinal chemistry, Apr-15, Volume: 19, Issue:8
In vitro and QSAR studies of cucurbitacins on HepG2 and HSC-T6 liver cell lines.
AID1225622Inhibition of HSP90 in human MCF7 cells assessed as Her2 degradation at 0.5 times to 5 times IC50 after 24 hrs by Western blot analysis2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID337992Inhibition of actin polymerization in fMLP-stimulated human neutrophils assessed as positive fluorescence signal at 3.3 uM1994Journal of natural products, Nov, Volume: 57, Issue:11
Cucurbitacins, cell adhesion inhibitors from Conobea scoparioides.
AID337983Cytotoxicity against human JY cells assessed as inhibition of thymidine uptake at 0.3 uM by scintillation counting1994Journal of natural products, Nov, Volume: 57, Issue:11
Cucurbitacins, cell adhesion inhibitors from Conobea scoparioides.
AID337994Effect on cell activation in human JY cells assessed as inhibition of Ca2+ flux1994Journal of natural products, Nov, Volume: 57, Issue:11
Cucurbitacins, cell adhesion inhibitors from Conobea scoparioides.
AID337995Inhibition of PKC in human JY cells1994Journal of natural products, Nov, Volume: 57, Issue:11
Cucurbitacins, cell adhesion inhibitors from Conobea scoparioides.
AID659253Cytotoxicity against human HT-29 cells after 3 days by sulforhodamine B assay2012Journal of natural products, Mar-23, Volume: 75, Issue:3
Isolation, structure elucidation, and biological evaluation of 16,23-epoxycucurbitacin constituents from Eleaocarpus chinensis.
AID1225621Inhibition of HSP90 in human MCF7 cells assessed as pAkt degradation at 0.5 times to 5 times IC50 after 24 hrs by Western blot analysis2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
AID337993Inhibition of actin polymerization in fMLP-stimulated human neutrophils assessed as positive fluorescence signal at 0.33 uM1994Journal of natural products, Nov, Volume: 57, Issue:11
Cucurbitacins, cell adhesion inhibitors from Conobea scoparioides.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (106)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (1.89)18.7374
1990's1 (0.94)18.2507
2000's26 (24.53)29.6817
2010's69 (65.09)24.3611
2020's8 (7.55)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.02 (24.57)
Research Supply Index4.71 (2.92)
Research Growth Index6.40 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (25.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (1.85%)5.53%
Reviews3 (2.78%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other103 (95.37%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]